| Primary |
| Drug Use For Unknown Indication |
37.5% |
| Atrial Fibrillation |
25.0% |
| Hypertension |
25.0% |
| Hyperuricaemia |
12.5% |
|
| Torsade De Pointes |
100.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
31.1% |
| Product Used For Unknown Indication |
18.9% |
| Atrial Fibrillation |
6.6% |
| Hypertension |
5.7% |
| Cardiac Failure |
4.9% |
| Lung Infection |
4.9% |
| Diabetes Mellitus |
4.1% |
| Insulin-requiring Type 2 Diabetes Mellitus |
3.3% |
| Hypokalaemia |
2.5% |
| Atrial Flutter |
1.6% |
| Cardiomyopathy |
1.6% |
| Cognitive Disorder |
1.6% |
| Dementia Alzheimer's Type |
1.6% |
| Depression |
1.6% |
| Duodenitis |
1.6% |
| Essential Hypertension |
1.6% |
| Haemangioma |
1.6% |
| Ischaemic Cardiomyopathy |
1.6% |
| Micturition Disorder |
1.6% |
| Pulmonary Embolism |
1.6% |
|
| Renal Failure |
17.2% |
| Hyperthyroidism |
6.9% |
| Pemphigoid |
6.9% |
| Self-induced Vomiting |
6.9% |
| Subdural Haematoma |
6.9% |
| Vomiting |
6.9% |
| Atrial Fibrillation |
3.4% |
| Cardiomegaly |
3.4% |
| Drug Interaction |
3.4% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
3.4% |
| Hepatitis |
3.4% |
| Leukopenia |
3.4% |
| Persecutory Delusion |
3.4% |
| Pitting Oedema |
3.4% |
| Renal Failure Acute |
3.4% |
| Rhabdomyolysis |
3.4% |
| Subdural Haematoma Evacuation |
3.4% |
| Syncope |
3.4% |
| Toxic Skin Eruption |
3.4% |
| White Blood Cell Count Increased |
3.4% |
|
| Concomitant |
| Drug Use For Unknown Indication |
42.1% |
| Product Used For Unknown Indication |
14.5% |
| Atrial Fibrillation |
8.4% |
| Hypertension |
6.3% |
| Cardiac Failure |
2.6% |
| Multiple Myeloma |
2.6% |
| Prophylaxis |
2.4% |
| Unevaluable Event |
2.2% |
| Bone Pain |
1.9% |
| Pneumonia |
1.9% |
| Arrhythmia |
1.8% |
| Osteitis |
1.8% |
| Depression |
1.7% |
| Pain |
1.6% |
| Pulmonary Arterial Hypertension |
1.6% |
| Cerebrovascular Accident Prophylaxis |
1.4% |
| Constipation |
1.4% |
| Urinary Tract Infection |
1.4% |
| Epilepsy |
1.3% |
| Hepatitis B |
1.2% |
|
| Renal Failure Acute |
12.3% |
| International Normalised Ratio Increased |
10.7% |
| Renal Failure |
9.8% |
| Thrombocytopenia |
8.2% |
| Vomiting |
7.4% |
| Toxic Skin Eruption |
5.7% |
| Weight Decreased |
4.9% |
| Oedema Peripheral |
4.1% |
| Rectal Haemorrhage |
4.1% |
| Haematoma |
3.3% |
| Hypoalbuminaemia |
3.3% |
| Neutropenia |
3.3% |
| Pleural Effusion |
3.3% |
| Respiratory Distress |
3.3% |
| Somnolence |
3.3% |
| Urinary Retention |
3.3% |
| Cardiac Arrest |
2.5% |
| Haemothorax |
2.5% |
| Left Ventricular Failure |
2.5% |
| Muscle Haemorrhage |
2.5% |
|
